Two of the top health care investors at the investment bank SVB Securities and the private equity giant KKR are starting a new biotech investment firm called Enavate Sciences. Enavate launched ...

Enavate Sciences joins Cormorant Asset Management, Pontifax Venture Capital and Ovid Therapeutics in supporting Graviton's development of ROCK2 inhibitors across multiple indications NEW YORK ...

MENLO PARK, Calif., Jan. 16, 2024 /PRNewswire/ -- Enavate Sciences, a portfolio company of Patient Square Capital, is pleased to announce that Christine Del Corsano has joined the firm as ...